Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

BACKGROUND: There exists evidence that body mass index (BMI) impacts on the efficacy of aromatase inhibitors in patients with breast cancer. The relationship between BMI and the efficacy of tamoxifen is conflicting. We investigated the impact of BMI on the efficacy of single tamoxifen and tamoxifen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pfeiler, G, Stöger, H, Dubsky, P, Mlineritsch, B, Singer, C, Balic, M, Fitzal, F, Moik, M, Kwasny, W, Selim, U, Renner, K, Ploner, F, Steger, G G, Seifert, M, Hofbauer, F, Sandbichler, P, Samonigg, H, Jakesz, R, Greil, R, Fesl, C, Gnant, M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629426/
https://ncbi.nlm.nih.gov/pubmed/23511562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.114
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak